
Novartis is to present data from four pivotal Phase III trials in two debilitating inflammatory diseases at the American College …

Abbott has launched a new online assessment tool that has the potential to change the landscape of ankylosing spondylitis (AS) …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

